Abstract

BiolatamA® is the biotechnology conference which provides unique access to Latin America, one of the fastest growing life science markets. International drug developers are increasingly targeting Latin America's emerging market and innovative capabilities in generic pharmaceuticals, clinical trials and drug manufacturing. As well, governmental support for biotechnology companies has increased dramatically over the last decade, lending to a ripe environment for life science partnering. Biolatam aims at promoting mutual benefits between global companies and US, Latin American and European entities, to facilitate life science investments and technological collaborations.